Trials / Sponsors / Centro Nacional de Investigaciones Oncologicas CARLOS III

Centro Nacional de Investigaciones Oncologicas CARLOS III

Academic / Other · 14 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	High Definition Medicine for Solid Tumors Oncology Metastatic Solid Tumor, Advanced Cancer	—	2023-03-02
Completed	ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Early-Stage Breast Carcinoma	EARLY_Phase 1	2016-07-01
Unknown	PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. Advanced Prostate Cancer, Castration Resistant, Enzalutamide	—	2016-06-01
Completed	Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER- Metastatic Breast Cancer, Bevacizumab-alone Maintenance Treatment Progression	EARLY_Phase 1	2016-05-01
Unknown	PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. Advanced Prostate Cancer, Castration Resistant, Radium 223	—	2016-02-01
Completed	Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics Breast Cancer	Phase 1	2015-07-01
Unknown	PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Caba Advanced Prostate Cancer, Cabazitaxel, Docetaxel	—	2014-05-01
Unknown	PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Aceta Advanced Prostate Cancer, Abiraterone ACetate	—	2014-05-01
Completed	SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone Prostate Cancer	Phase 2	2013-06-01
Completed	Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) Prostate Cancer	—	2013-01-15
Completed	Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Adenocarcinoma of Colon, Adenocarcinoma of Rectum, Metastatic Disease	Phase 2	2012-11-01
Terminated	Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Soli Solid Tumors	Phase 1	2012-04-01
Completed	Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Advanced Pancreatic Carcinoma	Phase 2	2011-10-01
Completed	Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer	Phase 1 / Phase 2	2011-10-01